Immune support

Thymosin Alpha-1

Tα1

Immune use; approved in some countries
Based on expert consensus from publicly available videos plus public FDA/regulatory status — not medical advice. Peptides are prescription territory; consult a physician before using anything here.

The Verdict

The immune peptide — real clinical history for immune support (more than the recovery peptides), used in clinician-led immune and long-COVID protocols. Still physician-led territory.

The Evidence

FDA / Legal Status

Approved in some countries for immune indications; not a US-marketed weight/longevity drug

Human Evidence

Clinical history in immune deficiency; used in long-COVID/immune protocols by some clinicians

Sport / Doping

Check sport status

Safety Flags

  • Regulatory availability varies and has shifted recently
  • Use should be clinician-led with monitoring

Who Covers It

Andrew Huberman
Andrew Huberman
Mark Hyman
Mark Hyman

Other experts in the panel had no substantive coverage of this peptide — we don't guess their position.

Want the deep dive on Thymosin Alpha-1?

This grade is free. Pro unlocks chat with the full expert dataset — ask about dosing, stacks, sourcing, and the exact citations behind every claim.

Cancel anytime

Go Deeper